{
    "matches": [
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "All children",
                    "Sample Size": "1024",
                    "CMV Viremia": "314 (30.7)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "59 (5.8)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[CMV Viremia (%)]",
                "outcomes": "[30.7%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "All children",
                    "Sample Size": "1024",
                    "CMV Viremia": "314 (30.7)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "59 (5.8)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                "outcomes": "[5.8%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "All children",
                    "Sample Size": "1024",
                    "CMV Viremia": "314 (30.7)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "59 (5.8)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                "outcomes": "[2.3 (1.9\u20132.7)]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "All children",
                    "Sample Size": "1024",
                    "CMV Viremia": "314 (30.7)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "59 (5.8)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[CMV Viremia (%)]",
                "outcomes": "[29.0%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "All children",
                    "Sample Size": "1024",
                    "CMV Viremia": "314 (30.7)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "59 (5.8)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                "outcomes": "[5.2%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "All children",
                    "Sample Size": "1024",
                    "CMV Viremia": "314 (30.7)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "59 (5.8)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                "outcomes": "[2.3 (1.9\u20132.7)]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "All children",
                    "Sample Size": "1024",
                    "CMV Viremia": "314 (30.7)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "59 (5.8)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[38.1%, 0.061]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "All children",
                    "Sample Size": "1024",
                    "CMV Viremia": "314 (30.7)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "59 (5.8)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[8.5%, 0.18]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "All children",
                    "Sample Size": "1024",
                    "CMV Viremia": "314 (30.7)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "59 (5.8)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[2.4 (2.0\u20132.9), 0.24]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "All children",
                    "Sample Size": "1024",
                    "CMV Viremia": "314 (30.7)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "59 (5.8)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[37.1%, 0.088]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "All children",
                    "Sample Size": "1024",
                    "CMV Viremia": "314 (30.7)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "59 (5.8)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[6.2%, 0.56]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "All children",
                    "Sample Size": "1024",
                    "CMV Viremia": "314 (30.7)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "59 (5.8)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[2.4 (1.9\u20132.7), 0.74]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "All children",
                    "Sample Size": "1024",
                    "CMV Viremia": "314 (30.7)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "59 (5.8)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[40.0%, 0.39]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "All children",
                    "Sample Size": "1024",
                    "CMV Viremia": "314 (30.7)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "59 (5.8)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[20.0%, 0.015]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "All children",
                    "Sample Size": "1024",
                    "CMV Viremia": "314 (30.7)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "59 (5.8)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[3.2 (2.6\u20135.3), 0.012]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV unexposed",
                    "Sample Size": "872",
                    "CMV Viremia": "253 (29.0)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "45 (5.2)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[253 (29.0), 45 (5.2), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[CMV Viremia (%)]",
                "outcomes": "[30.7%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV unexposed",
                    "Sample Size": "872",
                    "CMV Viremia": "253 (29.0)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "45 (5.2)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[253 (29.0), 45 (5.2), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                "outcomes": "[5.8%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV unexposed",
                    "Sample Size": "872",
                    "CMV Viremia": "253 (29.0)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "45 (5.2)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[253 (29.0), 45 (5.2), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                "outcomes": "[2.3 (1.9\u20132.7)]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV unexposed",
                    "Sample Size": "872",
                    "CMV Viremia": "253 (29.0)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "45 (5.2)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[253 (29.0), 45 (5.2), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[CMV Viremia (%)]",
                "outcomes": "[29.0%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV unexposed",
                    "Sample Size": "872",
                    "CMV Viremia": "253 (29.0)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "45 (5.2)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[253 (29.0), 45 (5.2), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                "outcomes": "[5.2%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV unexposed",
                    "Sample Size": "872",
                    "CMV Viremia": "253 (29.0)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "45 (5.2)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[253 (29.0), 45 (5.2), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                "outcomes": "[2.3 (1.9\u20132.7)]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV unexposed",
                    "Sample Size": "872",
                    "CMV Viremia": "253 (29.0)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "45 (5.2)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[253 (29.0), 45 (5.2), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[38.1%, 0.061]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV unexposed",
                    "Sample Size": "872",
                    "CMV Viremia": "253 (29.0)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "45 (5.2)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[253 (29.0), 45 (5.2), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[8.5%, 0.18]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV unexposed",
                    "Sample Size": "872",
                    "CMV Viremia": "253 (29.0)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "45 (5.2)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[253 (29.0), 45 (5.2), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[2.4 (2.0\u20132.9), 0.24]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV unexposed",
                    "Sample Size": "872",
                    "CMV Viremia": "253 (29.0)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "45 (5.2)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[253 (29.0), 45 (5.2), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[37.1%, 0.088]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV unexposed",
                    "Sample Size": "872",
                    "CMV Viremia": "253 (29.0)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "45 (5.2)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[253 (29.0), 45 (5.2), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[6.2%, 0.56]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV unexposed",
                    "Sample Size": "872",
                    "CMV Viremia": "253 (29.0)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "45 (5.2)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[253 (29.0), 45 (5.2), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[2.4 (1.9\u20132.7), 0.74]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV unexposed",
                    "Sample Size": "872",
                    "CMV Viremia": "253 (29.0)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "45 (5.2)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[253 (29.0), 45 (5.2), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[40.0%, 0.39]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV unexposed",
                    "Sample Size": "872",
                    "CMV Viremia": "253 (29.0)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "45 (5.2)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[253 (29.0), 45 (5.2), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[20.0%, 0.015]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV unexposed",
                    "Sample Size": "872",
                    "CMV Viremia": "253 (29.0)",
                    "P Value": "Not reported",
                    "CMV Viremia \u2264 1000 IU/mL": "45 (5.2)",
                    "log10 CMV IU/mL in Viremics": "2.3 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[253 (29.0), 45 (5.2), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[3.2 (2.6\u20135.3), 0.012]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed",
                    "Sample Size": "118",
                    "CMV Viremia": "45 (38.1)",
                    "P Value": "0.24",
                    "CMV Viremia \u2264 1000 IU/mL": "10 (8.5)",
                    "log10 CMV IU/mL in Viremics": "2.4 (2.0\u20132.9)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[45 (38.1), 10 (8.5), 2.4 (2.0\u20132.9)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[CMV Viremia (%)]",
                "outcomes": "[30.7%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed",
                    "Sample Size": "118",
                    "CMV Viremia": "45 (38.1)",
                    "P Value": "0.24",
                    "CMV Viremia \u2264 1000 IU/mL": "10 (8.5)",
                    "log10 CMV IU/mL in Viremics": "2.4 (2.0\u20132.9)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[45 (38.1), 10 (8.5), 2.4 (2.0\u20132.9)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                "outcomes": "[5.8%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed",
                    "Sample Size": "118",
                    "CMV Viremia": "45 (38.1)",
                    "P Value": "0.24",
                    "CMV Viremia \u2264 1000 IU/mL": "10 (8.5)",
                    "log10 CMV IU/mL in Viremics": "2.4 (2.0\u20132.9)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[45 (38.1), 10 (8.5), 2.4 (2.0\u20132.9)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                "outcomes": "[2.3 (1.9\u20132.7)]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed",
                    "Sample Size": "118",
                    "CMV Viremia": "45 (38.1)",
                    "P Value": "0.24",
                    "CMV Viremia \u2264 1000 IU/mL": "10 (8.5)",
                    "log10 CMV IU/mL in Viremics": "2.4 (2.0\u20132.9)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[45 (38.1), 10 (8.5), 2.4 (2.0\u20132.9)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[CMV Viremia (%)]",
                "outcomes": "[29.0%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed",
                    "Sample Size": "118",
                    "CMV Viremia": "45 (38.1)",
                    "P Value": "0.24",
                    "CMV Viremia \u2264 1000 IU/mL": "10 (8.5)",
                    "log10 CMV IU/mL in Viremics": "2.4 (2.0\u20132.9)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[45 (38.1), 10 (8.5), 2.4 (2.0\u20132.9)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                "outcomes": "[5.2%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed",
                    "Sample Size": "118",
                    "CMV Viremia": "45 (38.1)",
                    "P Value": "0.24",
                    "CMV Viremia \u2264 1000 IU/mL": "10 (8.5)",
                    "log10 CMV IU/mL in Viremics": "2.4 (2.0\u20132.9)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[45 (38.1), 10 (8.5), 2.4 (2.0\u20132.9)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                "outcomes": "[2.3 (1.9\u20132.7)]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed",
                    "Sample Size": "118",
                    "CMV Viremia": "45 (38.1)",
                    "P Value": "0.24",
                    "CMV Viremia \u2264 1000 IU/mL": "10 (8.5)",
                    "log10 CMV IU/mL in Viremics": "2.4 (2.0\u20132.9)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[45 (38.1), 10 (8.5), 2.4 (2.0\u20132.9)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[38.1%, 0.061]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed",
                    "Sample Size": "118",
                    "CMV Viremia": "45 (38.1)",
                    "P Value": "0.24",
                    "CMV Viremia \u2264 1000 IU/mL": "10 (8.5)",
                    "log10 CMV IU/mL in Viremics": "2.4 (2.0\u20132.9)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[45 (38.1), 10 (8.5), 2.4 (2.0\u20132.9)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[8.5%, 0.18]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed",
                    "Sample Size": "118",
                    "CMV Viremia": "45 (38.1)",
                    "P Value": "0.24",
                    "CMV Viremia \u2264 1000 IU/mL": "10 (8.5)",
                    "log10 CMV IU/mL in Viremics": "2.4 (2.0\u20132.9)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[45 (38.1), 10 (8.5), 2.4 (2.0\u20132.9)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[2.4 (2.0\u20132.9), 0.24]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed",
                    "Sample Size": "118",
                    "CMV Viremia": "45 (38.1)",
                    "P Value": "0.24",
                    "CMV Viremia \u2264 1000 IU/mL": "10 (8.5)",
                    "log10 CMV IU/mL in Viremics": "2.4 (2.0\u20132.9)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[45 (38.1), 10 (8.5), 2.4 (2.0\u20132.9)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[37.1%, 0.088]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed",
                    "Sample Size": "118",
                    "CMV Viremia": "45 (38.1)",
                    "P Value": "0.24",
                    "CMV Viremia \u2264 1000 IU/mL": "10 (8.5)",
                    "log10 CMV IU/mL in Viremics": "2.4 (2.0\u20132.9)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[45 (38.1), 10 (8.5), 2.4 (2.0\u20132.9)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[6.2%, 0.56]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed",
                    "Sample Size": "118",
                    "CMV Viremia": "45 (38.1)",
                    "P Value": "0.24",
                    "CMV Viremia \u2264 1000 IU/mL": "10 (8.5)",
                    "log10 CMV IU/mL in Viremics": "2.4 (2.0\u20132.9)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[45 (38.1), 10 (8.5), 2.4 (2.0\u20132.9)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[2.4 (1.9\u20132.7), 0.74]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed",
                    "Sample Size": "118",
                    "CMV Viremia": "45 (38.1)",
                    "P Value": "0.24",
                    "CMV Viremia \u2264 1000 IU/mL": "10 (8.5)",
                    "log10 CMV IU/mL in Viremics": "2.4 (2.0\u20132.9)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[45 (38.1), 10 (8.5), 2.4 (2.0\u20132.9)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[40.0%, 0.39]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed",
                    "Sample Size": "118",
                    "CMV Viremia": "45 (38.1)",
                    "P Value": "0.24",
                    "CMV Viremia \u2264 1000 IU/mL": "10 (8.5)",
                    "log10 CMV IU/mL in Viremics": "2.4 (2.0\u20132.9)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[45 (38.1), 10 (8.5), 2.4 (2.0\u20132.9)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[20.0%, 0.015]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed",
                    "Sample Size": "118",
                    "CMV Viremia": "45 (38.1)",
                    "P Value": "0.24",
                    "CMV Viremia \u2264 1000 IU/mL": "10 (8.5)",
                    "log10 CMV IU/mL in Viremics": "2.4 (2.0\u20132.9)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[45 (38.1), 10 (8.5), 2.4 (2.0\u20132.9)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[3.2 (2.6\u20135.3), 0.012]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed uninfected",
                    "Sample Size": "97",
                    "CMV Viremia": "36 (37.1)",
                    "P Value": "0.74",
                    "CMV Viremia \u2264 1000 IU/mL": "6 (6.2)",
                    "log10 CMV IU/mL in Viremics": "2.4 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[36 (37.1), 6 (6.2), 2.4 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[CMV Viremia (%)]",
                "outcomes": "[30.7%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed uninfected",
                    "Sample Size": "97",
                    "CMV Viremia": "36 (37.1)",
                    "P Value": "0.74",
                    "CMV Viremia \u2264 1000 IU/mL": "6 (6.2)",
                    "log10 CMV IU/mL in Viremics": "2.4 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[36 (37.1), 6 (6.2), 2.4 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                "outcomes": "[5.8%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed uninfected",
                    "Sample Size": "97",
                    "CMV Viremia": "36 (37.1)",
                    "P Value": "0.74",
                    "CMV Viremia \u2264 1000 IU/mL": "6 (6.2)",
                    "log10 CMV IU/mL in Viremics": "2.4 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[36 (37.1), 6 (6.2), 2.4 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                "outcomes": "[2.3 (1.9\u20132.7)]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed uninfected",
                    "Sample Size": "97",
                    "CMV Viremia": "36 (37.1)",
                    "P Value": "0.74",
                    "CMV Viremia \u2264 1000 IU/mL": "6 (6.2)",
                    "log10 CMV IU/mL in Viremics": "2.4 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[36 (37.1), 6 (6.2), 2.4 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[CMV Viremia (%)]",
                "outcomes": "[29.0%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed uninfected",
                    "Sample Size": "97",
                    "CMV Viremia": "36 (37.1)",
                    "P Value": "0.74",
                    "CMV Viremia \u2264 1000 IU/mL": "6 (6.2)",
                    "log10 CMV IU/mL in Viremics": "2.4 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[36 (37.1), 6 (6.2), 2.4 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                "outcomes": "[5.2%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed uninfected",
                    "Sample Size": "97",
                    "CMV Viremia": "36 (37.1)",
                    "P Value": "0.74",
                    "CMV Viremia \u2264 1000 IU/mL": "6 (6.2)",
                    "log10 CMV IU/mL in Viremics": "2.4 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[36 (37.1), 6 (6.2), 2.4 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                "outcomes": "[2.3 (1.9\u20132.7)]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed uninfected",
                    "Sample Size": "97",
                    "CMV Viremia": "36 (37.1)",
                    "P Value": "0.74",
                    "CMV Viremia \u2264 1000 IU/mL": "6 (6.2)",
                    "log10 CMV IU/mL in Viremics": "2.4 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[36 (37.1), 6 (6.2), 2.4 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[38.1%, 0.061]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed uninfected",
                    "Sample Size": "97",
                    "CMV Viremia": "36 (37.1)",
                    "P Value": "0.74",
                    "CMV Viremia \u2264 1000 IU/mL": "6 (6.2)",
                    "log10 CMV IU/mL in Viremics": "2.4 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[36 (37.1), 6 (6.2), 2.4 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[8.5%, 0.18]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed uninfected",
                    "Sample Size": "97",
                    "CMV Viremia": "36 (37.1)",
                    "P Value": "0.74",
                    "CMV Viremia \u2264 1000 IU/mL": "6 (6.2)",
                    "log10 CMV IU/mL in Viremics": "2.4 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[36 (37.1), 6 (6.2), 2.4 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[2.4 (2.0\u20132.9), 0.24]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed uninfected",
                    "Sample Size": "97",
                    "CMV Viremia": "36 (37.1)",
                    "P Value": "0.74",
                    "CMV Viremia \u2264 1000 IU/mL": "6 (6.2)",
                    "log10 CMV IU/mL in Viremics": "2.4 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[36 (37.1), 6 (6.2), 2.4 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[37.1%, 0.088]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed uninfected",
                    "Sample Size": "97",
                    "CMV Viremia": "36 (37.1)",
                    "P Value": "0.74",
                    "CMV Viremia \u2264 1000 IU/mL": "6 (6.2)",
                    "log10 CMV IU/mL in Viremics": "2.4 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[36 (37.1), 6 (6.2), 2.4 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[6.2%, 0.56]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed uninfected",
                    "Sample Size": "97",
                    "CMV Viremia": "36 (37.1)",
                    "P Value": "0.74",
                    "CMV Viremia \u2264 1000 IU/mL": "6 (6.2)",
                    "log10 CMV IU/mL in Viremics": "2.4 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[36 (37.1), 6 (6.2), 2.4 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[2.4 (1.9\u20132.7), 0.74]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed uninfected",
                    "Sample Size": "97",
                    "CMV Viremia": "36 (37.1)",
                    "P Value": "0.74",
                    "CMV Viremia \u2264 1000 IU/mL": "6 (6.2)",
                    "log10 CMV IU/mL in Viremics": "2.4 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[36 (37.1), 6 (6.2), 2.4 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[40.0%, 0.39]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed uninfected",
                    "Sample Size": "97",
                    "CMV Viremia": "36 (37.1)",
                    "P Value": "0.74",
                    "CMV Viremia \u2264 1000 IU/mL": "6 (6.2)",
                    "log10 CMV IU/mL in Viremics": "2.4 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[36 (37.1), 6 (6.2), 2.4 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[20.0%, 0.015]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV exposed uninfected",
                    "Sample Size": "97",
                    "CMV Viremia": "36 (37.1)",
                    "P Value": "0.74",
                    "CMV Viremia \u2264 1000 IU/mL": "6 (6.2)",
                    "log10 CMV IU/mL in Viremics": "2.4 (1.9\u20132.7)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[36 (37.1), 6 (6.2), 2.4 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[3.2 (2.6\u20135.3), 0.012]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV infected",
                    "Sample Size": "15",
                    "CMV Viremia": "6 (40.0)",
                    "P Value": "0.012",
                    "CMV Viremia \u2264 1000 IU/mL": "3 (20.0)",
                    "log10 CMV IU/mL in Viremics": "3.2 (2.6\u20135.3)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[6 (40.0), 3 (20.0), 3.2 (2.6\u20135.3)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[CMV Viremia (%)]",
                "outcomes": "[30.7%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV infected",
                    "Sample Size": "15",
                    "CMV Viremia": "6 (40.0)",
                    "P Value": "0.012",
                    "CMV Viremia \u2264 1000 IU/mL": "3 (20.0)",
                    "log10 CMV IU/mL in Viremics": "3.2 (2.6\u20135.3)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[6 (40.0), 3 (20.0), 3.2 (2.6\u20135.3)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                "outcomes": "[5.8%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV infected",
                    "Sample Size": "15",
                    "CMV Viremia": "6 (40.0)",
                    "P Value": "0.012",
                    "CMV Viremia \u2264 1000 IU/mL": "3 (20.0)",
                    "log10 CMV IU/mL in Viremics": "3.2 (2.6\u20135.3)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[6 (40.0), 3 (20.0), 3.2 (2.6\u20135.3)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                "outcomes": "[2.3 (1.9\u20132.7)]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV infected",
                    "Sample Size": "15",
                    "CMV Viremia": "6 (40.0)",
                    "P Value": "0.012",
                    "CMV Viremia \u2264 1000 IU/mL": "3 (20.0)",
                    "log10 CMV IU/mL in Viremics": "3.2 (2.6\u20135.3)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[6 (40.0), 3 (20.0), 3.2 (2.6\u20135.3)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[CMV Viremia (%)]",
                "outcomes": "[29.0%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV infected",
                    "Sample Size": "15",
                    "CMV Viremia": "6 (40.0)",
                    "P Value": "0.012",
                    "CMV Viremia \u2264 1000 IU/mL": "3 (20.0)",
                    "log10 CMV IU/mL in Viremics": "3.2 (2.6\u20135.3)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[6 (40.0), 3 (20.0), 3.2 (2.6\u20135.3)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                "outcomes": "[5.2%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV infected",
                    "Sample Size": "15",
                    "CMV Viremia": "6 (40.0)",
                    "P Value": "0.012",
                    "CMV Viremia \u2264 1000 IU/mL": "3 (20.0)",
                    "log10 CMV IU/mL in Viremics": "3.2 (2.6\u20135.3)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[6 (40.0), 3 (20.0), 3.2 (2.6\u20135.3)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                "outcomes": "[2.3 (1.9\u20132.7)]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV infected",
                    "Sample Size": "15",
                    "CMV Viremia": "6 (40.0)",
                    "P Value": "0.012",
                    "CMV Viremia \u2264 1000 IU/mL": "3 (20.0)",
                    "log10 CMV IU/mL in Viremics": "3.2 (2.6\u20135.3)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[6 (40.0), 3 (20.0), 3.2 (2.6\u20135.3)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[38.1%, 0.061]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV infected",
                    "Sample Size": "15",
                    "CMV Viremia": "6 (40.0)",
                    "P Value": "0.012",
                    "CMV Viremia \u2264 1000 IU/mL": "3 (20.0)",
                    "log10 CMV IU/mL in Viremics": "3.2 (2.6\u20135.3)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[6 (40.0), 3 (20.0), 3.2 (2.6\u20135.3)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[8.5%, 0.18]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV infected",
                    "Sample Size": "15",
                    "CMV Viremia": "6 (40.0)",
                    "P Value": "0.012",
                    "CMV Viremia \u2264 1000 IU/mL": "3 (20.0)",
                    "log10 CMV IU/mL in Viremics": "3.2 (2.6\u20135.3)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[6 (40.0), 3 (20.0), 3.2 (2.6\u20135.3)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[2.4 (2.0\u20132.9), 0.24]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV infected",
                    "Sample Size": "15",
                    "CMV Viremia": "6 (40.0)",
                    "P Value": "0.012",
                    "CMV Viremia \u2264 1000 IU/mL": "3 (20.0)",
                    "log10 CMV IU/mL in Viremics": "3.2 (2.6\u20135.3)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[6 (40.0), 3 (20.0), 3.2 (2.6\u20135.3)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[37.1%, 0.088]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV infected",
                    "Sample Size": "15",
                    "CMV Viremia": "6 (40.0)",
                    "P Value": "0.012",
                    "CMV Viremia \u2264 1000 IU/mL": "3 (20.0)",
                    "log10 CMV IU/mL in Viremics": "3.2 (2.6\u20135.3)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[6 (40.0), 3 (20.0), 3.2 (2.6\u20135.3)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[6.2%, 0.56]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV infected",
                    "Sample Size": "15",
                    "CMV Viremia": "6 (40.0)",
                    "P Value": "0.012",
                    "CMV Viremia \u2264 1000 IU/mL": "3 (20.0)",
                    "log10 CMV IU/mL in Viremics": "3.2 (2.6\u20135.3)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[6 (40.0), 3 (20.0), 3.2 (2.6\u20135.3)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[2.4 (1.9\u20132.7), 0.74]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV infected",
                    "Sample Size": "15",
                    "CMV Viremia": "6 (40.0)",
                    "P Value": "0.012",
                    "CMV Viremia \u2264 1000 IU/mL": "3 (20.0)",
                    "log10 CMV IU/mL in Viremics": "3.2 (2.6\u20135.3)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[6 (40.0), 3 (20.0), 3.2 (2.6\u20135.3)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[40.0%, 0.39]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV infected",
                    "Sample Size": "15",
                    "CMV Viremia": "6 (40.0)",
                    "P Value": "0.012",
                    "CMV Viremia \u2264 1000 IU/mL": "3 (20.0)",
                    "log10 CMV IU/mL in Viremics": "3.2 (2.6\u20135.3)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[6 (40.0), 3 (20.0), 3.2 (2.6\u20135.3)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[20.0%, 0.015]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study Population": "HIV infected",
                    "Sample Size": "15",
                    "CMV Viremia": "6 (40.0)",
                    "P Value": "0.012",
                    "CMV Viremia \u2264 1000 IU/mL": "3 (20.0)",
                    "log10 CMV IU/mL in Viremics": "3.2 (2.6\u20135.3)"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[6 (40.0), 3 (20.0), 3.2 (2.6\u20135.3)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[3.2 (2.6\u20135.3), 0.012]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Citation": "At hospital discharge, 314 children had detectable CMV viremia (31%), with 5.8% having CMV levels \u2264 1000 IU/mL (Table 2).",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[CMV Viremia (%)]",
                "outcomes": "[30.7%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Citation": "At hospital discharge, 314 children had detectable CMV viremia (31%), with 5.8% having CMV levels \u2264 1000 IU/mL (Table 2).",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                "outcomes": "[5.8%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Citation": "At hospital discharge, 314 children had detectable CMV viremia (31%), with 5.8% having CMV levels \u2264 1000 IU/mL (Table 2).",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                "outcomes": "[2.3 (1.9\u20132.7)]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Citation": "At hospital discharge, 314 children had detectable CMV viremia (31%), with 5.8% having CMV levels \u2264 1000 IU/mL (Table 2).",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[CMV Viremia (%)]",
                "outcomes": "[29.0%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Citation": "At hospital discharge, 314 children had detectable CMV viremia (31%), with 5.8% having CMV levels \u2264 1000 IU/mL (Table 2).",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                "outcomes": "[5.2%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Citation": "At hospital discharge, 314 children had detectable CMV viremia (31%), with 5.8% having CMV levels \u2264 1000 IU/mL (Table 2).",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                "outcomes": "[2.3 (1.9\u20132.7)]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Citation": "At hospital discharge, 314 children had detectable CMV viremia (31%), with 5.8% having CMV levels \u2264 1000 IU/mL (Table 2).",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[38.1%, 0.061]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Citation": "At hospital discharge, 314 children had detectable CMV viremia (31%), with 5.8% having CMV levels \u2264 1000 IU/mL (Table 2).",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[8.5%, 0.18]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Citation": "At hospital discharge, 314 children had detectable CMV viremia (31%), with 5.8% having CMV levels \u2264 1000 IU/mL (Table 2).",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[2.4 (2.0\u20132.9), 0.24]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Citation": "At hospital discharge, 314 children had detectable CMV viremia (31%), with 5.8% having CMV levels \u2264 1000 IU/mL (Table 2).",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[37.1%, 0.088]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Citation": "At hospital discharge, 314 children had detectable CMV viremia (31%), with 5.8% having CMV levels \u2264 1000 IU/mL (Table 2).",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[6.2%, 0.56]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Citation": "At hospital discharge, 314 children had detectable CMV viremia (31%), with 5.8% having CMV levels \u2264 1000 IU/mL (Table 2).",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[2.4 (1.9\u20132.7), 0.74]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Citation": "At hospital discharge, 314 children had detectable CMV viremia (31%), with 5.8% having CMV levels \u2264 1000 IU/mL (Table 2).",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[40.0%, 0.39]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Citation": "At hospital discharge, 314 children had detectable CMV viremia (31%), with 5.8% having CMV levels \u2264 1000 IU/mL (Table 2).",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[20.0%, 0.015]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Citation": "At hospital discharge, 314 children had detectable CMV viremia (31%), with 5.8% having CMV levels \u2264 1000 IU/mL (Table 2).",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[3.2 (2.6\u20135.3), 0.012]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Caption": "CMV detection, high-level viremia, and median viral loads among hospitalized children, stratified by HIV exposure or infection.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[CMV Viremia (%)]",
                "outcomes": "[30.7%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Caption": "CMV detection, high-level viremia, and median viral loads among hospitalized children, stratified by HIV exposure or infection.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                "outcomes": "[5.8%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Caption": "CMV detection, high-level viremia, and median viral loads among hospitalized children, stratified by HIV exposure or infection.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                "outcomes": "[2.3 (1.9\u20132.7)]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Caption": "CMV detection, high-level viremia, and median viral loads among hospitalized children, stratified by HIV exposure or infection.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[CMV Viremia (%)]",
                "outcomes": "[29.0%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Caption": "CMV detection, high-level viremia, and median viral loads among hospitalized children, stratified by HIV exposure or infection.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                "outcomes": "[5.2%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Caption": "CMV detection, high-level viremia, and median viral loads among hospitalized children, stratified by HIV exposure or infection.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                "outcomes": "[2.3 (1.9\u20132.7)]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Caption": "CMV detection, high-level viremia, and median viral loads among hospitalized children, stratified by HIV exposure or infection.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[38.1%, 0.061]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Caption": "CMV detection, high-level viremia, and median viral loads among hospitalized children, stratified by HIV exposure or infection.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[8.5%, 0.18]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Caption": "CMV detection, high-level viremia, and median viral loads among hospitalized children, stratified by HIV exposure or infection.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[2.4 (2.0\u20132.9), 0.24]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Caption": "CMV detection, high-level viremia, and median viral loads among hospitalized children, stratified by HIV exposure or infection.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[37.1%, 0.088]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Caption": "CMV detection, high-level viremia, and median viral loads among hospitalized children, stratified by HIV exposure or infection.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[6.2%, 0.56]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Caption": "CMV detection, high-level viremia, and median viral loads among hospitalized children, stratified by HIV exposure or infection.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[2.4 (1.9\u20132.7), 0.74]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Caption": "CMV detection, high-level viremia, and median viral loads among hospitalized children, stratified by HIV exposure or infection.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[40.0%, 0.39]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Caption": "CMV detection, high-level viremia, and median viral loads among hospitalized children, stratified by HIV exposure or infection.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[20.0%, 0.015]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Caption": "CMV detection, high-level viremia, and median viral loads among hospitalized children, stratified by HIV exposure or infection.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[3.2 (2.6\u20135.3), 0.012]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Footnote": "a. HIV-exposed or infected group includes 6 children who were HIV exposed but whose HIV infection status was unknown. b. Comparison to CMV detection in HIV-unexposed children, \u03c7\u00b2 test. c. Comparison to CMV detection \u2264 1000 IU/mL in HIV-unexposed children, \u03c7\u00b2 test. d. Comparison of CMV viral load distribution to HIV-unexposed children, Wilcoxon rank-sum test.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[CMV Viremia (%)]",
                "outcomes": "[30.7%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Footnote": "a. HIV-exposed or infected group includes 6 children who were HIV exposed but whose HIV infection status was unknown. b. Comparison to CMV detection in HIV-unexposed children, \u03c7\u00b2 test. c. Comparison to CMV detection \u2264 1000 IU/mL in HIV-unexposed children, \u03c7\u00b2 test. d. Comparison of CMV viral load distribution to HIV-unexposed children, Wilcoxon rank-sum test.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                "outcomes": "[5.8%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Footnote": "a. HIV-exposed or infected group includes 6 children who were HIV exposed but whose HIV infection status was unknown. b. Comparison to CMV detection in HIV-unexposed children, \u03c7\u00b2 test. c. Comparison to CMV detection \u2264 1000 IU/mL in HIV-unexposed children, \u03c7\u00b2 test. d. Comparison of CMV viral load distribution to HIV-unexposed children, Wilcoxon rank-sum test.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "All children",
                    "Total No.": "1024",
                    "Method": "Overall CMV viremia analysis across all groups"
                },
                "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                "outcomes": "[2.3 (1.9\u20132.7)]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Footnote": "a. HIV-exposed or infected group includes 6 children who were HIV exposed but whose HIV infection status was unknown. b. Comparison to CMV detection in HIV-unexposed children, \u03c7\u00b2 test. c. Comparison to CMV detection \u2264 1000 IU/mL in HIV-unexposed children, \u03c7\u00b2 test. d. Comparison of CMV viral load distribution to HIV-unexposed children, Wilcoxon rank-sum test.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[CMV Viremia (%)]",
                "outcomes": "[29.0%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Footnote": "a. HIV-exposed or infected group includes 6 children who were HIV exposed but whose HIV infection status was unknown. b. Comparison to CMV detection in HIV-unexposed children, \u03c7\u00b2 test. c. Comparison to CMV detection \u2264 1000 IU/mL in HIV-unexposed children, \u03c7\u00b2 test. d. Comparison of CMV viral load distribution to HIV-unexposed children, Wilcoxon rank-sum test.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                "outcomes": "[5.2%]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Footnote": "a. HIV-exposed or infected group includes 6 children who were HIV exposed but whose HIV infection status was unknown. b. Comparison to CMV detection in HIV-unexposed children, \u03c7\u00b2 test. c. Comparison to CMV detection \u2264 1000 IU/mL in HIV-unexposed children, \u03c7\u00b2 test. d. Comparison of CMV viral load distribution to HIV-unexposed children, Wilcoxon rank-sum test.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV unexposed",
                    "Total No.": "872",
                    "Method": "Reference group for all comparisons"
                },
                "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                "outcomes": "[2.3 (1.9\u20132.7)]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Footnote": "a. HIV-exposed or infected group includes 6 children who were HIV exposed but whose HIV infection status was unknown. b. Comparison to CMV detection in HIV-unexposed children, \u03c7\u00b2 test. c. Comparison to CMV detection \u2264 1000 IU/mL in HIV-unexposed children, \u03c7\u00b2 test. d. Comparison of CMV viral load distribution to HIV-unexposed children, Wilcoxon rank-sum test.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[38.1%, 0.061]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Footnote": "a. HIV-exposed or infected group includes 6 children who were HIV exposed but whose HIV infection status was unknown. b. Comparison to CMV detection in HIV-unexposed children, \u03c7\u00b2 test. c. Comparison to CMV detection \u2264 1000 IU/mL in HIV-unexposed children, \u03c7\u00b2 test. d. Comparison of CMV viral load distribution to HIV-unexposed children, Wilcoxon rank-sum test.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[8.5%, 0.18]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Footnote": "a. HIV-exposed or infected group includes 6 children who were HIV exposed but whose HIV infection status was unknown. b. Comparison to CMV detection in HIV-unexposed children, \u03c7\u00b2 test. c. Comparison to CMV detection \u2264 1000 IU/mL in HIV-unexposed children, \u03c7\u00b2 test. d. Comparison of CMV viral load distribution to HIV-unexposed children, Wilcoxon rank-sum test.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed",
                    "Total No.": "118",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[2.4 (2.0\u20132.9), 0.24]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Footnote": "a. HIV-exposed or infected group includes 6 children who were HIV exposed but whose HIV infection status was unknown. b. Comparison to CMV detection in HIV-unexposed children, \u03c7\u00b2 test. c. Comparison to CMV detection \u2264 1000 IU/mL in HIV-unexposed children, \u03c7\u00b2 test. d. Comparison of CMV viral load distribution to HIV-unexposed children, Wilcoxon rank-sum test.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[37.1%, 0.088]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Footnote": "a. HIV-exposed or infected group includes 6 children who were HIV exposed but whose HIV infection status was unknown. b. Comparison to CMV detection in HIV-unexposed children, \u03c7\u00b2 test. c. Comparison to CMV detection \u2264 1000 IU/mL in HIV-unexposed children, \u03c7\u00b2 test. d. Comparison of CMV viral load distribution to HIV-unexposed children, Wilcoxon rank-sum test.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[6.2%, 0.56]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Footnote": "a. HIV-exposed or infected group includes 6 children who were HIV exposed but whose HIV infection status was unknown. b. Comparison to CMV detection in HIV-unexposed children, \u03c7\u00b2 test. c. Comparison to CMV detection \u2264 1000 IU/mL in HIV-unexposed children, \u03c7\u00b2 test. d. Comparison of CMV viral load distribution to HIV-unexposed children, Wilcoxon rank-sum test.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV exposed uninfected",
                    "Total No.": "97",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[2.4 (1.9\u20132.7), 0.74]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Footnote": "a. HIV-exposed or infected group includes 6 children who were HIV exposed but whose HIV infection status was unknown. b. Comparison to CMV detection in HIV-unexposed children, \u03c7\u00b2 test. c. Comparison to CMV detection \u2264 1000 IU/mL in HIV-unexposed children, \u03c7\u00b2 test. d. Comparison of CMV viral load distribution to HIV-unexposed children, Wilcoxon rank-sum test.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia (%), P Value]",
                "outcomes": "[40.0%, 0.39]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Footnote": "a. HIV-exposed or infected group includes 6 children who were HIV exposed but whose HIV infection status was unknown. b. Comparison to CMV detection in HIV-unexposed children, \u03c7\u00b2 test. c. Comparison to CMV detection \u2264 1000 IU/mL in HIV-unexposed children, \u03c7\u00b2 test. d. Comparison of CMV viral load distribution to HIV-unexposed children, Wilcoxon rank-sum test.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                "outcomes": "[20.0%, 0.015]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Footnote": "a. HIV-exposed or infected group includes 6 children who were HIV exposed but whose HIV infection status was unknown. b. Comparison to CMV detection in HIV-unexposed children, \u03c7\u00b2 test. c. Comparison to CMV detection \u2264 1000 IU/mL in HIV-unexposed children, \u03c7\u00b2 test. d. Comparison of CMV viral load distribution to HIV-unexposed children, Wilcoxon rank-sum test.",
                    "Study Type": "Observational",
                    "Population": "Hospitalized children",
                    "Outcome": "CMV detection, high-level viremia, and median viral loads"
                },
                "measures": "[CMV Viremia, CMV Viremia \u2264 1000 IU/mL, log10 CMV IU/mL in Viremics]",
                "outcomes": "[314 (30.7), 59 (5.8), 2.3 (1.9\u20132.7)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "HIV Status": "HIV infected",
                    "Total No.": "15",
                    "Method": "Comparison to HIV unexposed group"
                },
                "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                "outcomes": "[3.2 (2.6\u20135.3), 0.012]"
            },
            "match": "no"
        }
    ],
    "total_extracted_claims": 8,
    "total_ground_truth_claims": 15,
    "number_of_matches": 0
}